KIMBERLY GIBERGA: Open Payments
NPI 1114250651 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,408 in 141 payments from 21 companies in 2025. Trend: 2023 $1,955 · 2024 $4,723 · 2025 $27,408
Speaker / faculty: $22,000Food & beverage: $5,304Travel & lodging: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $23,249 |
| Axsome Therapeutics, Inc. | 16 | $715 |
| Boston Scientific Corporation | 3 | $403 |
| Teva Pharmaceuticals USA, Inc. | 8 | $378 |
| Janssen Pharmaceuticals, Inc | 8 | $341 |
| ABIOMED | 3 | $286 |
| E.R. Squibb & Sons, L.L.C. | 4 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $231 |
| Alkermes, Inc. | 4 | $207 |
| Lundbeck LLC | 8 | $182 |
Products named: VRAYLAR, Auvelity, REXULTI, SPRAVATO, COBENFY, AMS 700, CAPLYTA, LYBALVI.
Industry payments across TX — which companies pay providers there.
